Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01838798
Other study ID # LOCAL/2012/CR-02
Secondary ID 2013-A00022-43
Status Completed
Phase N/A
First received April 21, 2013
Last updated October 24, 2016
Start date November 2013
Est. completion date October 2016

Study information

Verified date October 2016
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority France: Committee for the Protection of PersonnesFrance: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Observational

Clinical Trial Summary

This is a prospective, single-center, pilot, cohort study. The first phase of this study is observational and the usual care of patients is maintained during the ICU stay, except for an interview with a psychologist preceding patient discharge. A phone interview at 2 months and a visit with a psychologist at four months after ICU discharge are specific to the study.

The main objective of this study is to make a first estimate of the percentage of patients (CI = +- 10%) with cognitive impairment at four months after ICU discharge. The presence / absence of cognitive impairment will be determined by the D2 test.


Description:

The secondary objectives of this study are:

A. To study the potential links between cognitive impairment and quality of life 4 months after discharge from the Intensive Care Unit.

B. To study the associations between variables measured during hospitalization. Is there "clustering" among certain symptoms during hospitalization?

C. To study the associations between variables measured at two and four months after ICU discharge. Is there clustering among these symptoms?

D. To study potential risk factors for cognitive problems at 4 months after ICU discharge.

E. If objective C determines the presence of clusters, is the presence / absence of these clusters related to the variables (or clusters of variables) measured during hospitalization?

F. To study potential risk factors for poor quality of life at 4 months:


Recruitment information / eligibility

Status Completed
Enrollment 125
Est. completion date October 2016
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient (or his/her "trusted person") must have given his/her informed and signed consent

- The patient must be insured or beneficiary of a health insurance plan

- The patient is available for a telephone interview at 2 months after ICU discharge, and for a follow-up visit at 4 months after ICU discharge

- Patient admitted to the ICU and intubated and ventilated for at least 48 hours

Exclusion Criteria:

- The patient is currently participating in or has participated in another study (within the past 3 months) that might influence the results of the current study

- The patient is under judicial protection, under tutorship or curatorship

- The patient refuses to sign the consent

- It is impossible to correctly inform the patient

- The patient is pregnant, parturient, or breastfeeding

- The patient has a contra-indication for a treatment used in this study

- Patient admitted to intensive care with sedation started for more than 24 hours

- Patient with neurological or psychiatric (cognitive) disorders

- Patient admitted for cardiac arrest

- Patient admitted for stroke

- Patient admitted for cervical trauma > C6

- Patient presenting with tracheotomy accompanied by long-term mechanical ventilation

- Moribund patient or with little hope of survival beyond 48 hours

- Patients for whom a limitation or termination of care is considered

- McCabe Score = 0

- Knauss Scale = C or D

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Other:
Baseline activities
Initial consent procedures and baseline data collection.
Clinical interview with a psychologist
Clinical interview with a psychologist. This interview with a psychologist will take place after patient consent procedures, and at least 2 days after discontinuation of sedation, and before leaving the ICU. This interview will include: An inventory of peritraumatic distress symptoms A questionnaire on peritraumatic dissociative experiences An assessment of related, potential impacts The HADS questionnaire
Telephone interview 2 months after ICU discharge
At 2 months after leaving the ICU, a psychologist will contact the patient with questions regarding his/her representation of hospitalization. This implies the following: Questionnaires assessing memories and stressors (Questionnaires ICUMT, and ICU-SEQ An assessment of psychological trauma An assessment of potential impacts
Clinical interview with a psychologist
At 4 months after ICU discharge, the patient has a clinical interview during which a psychologist will: assess cognitive functions evaluate clinical symptoms of depression assess quality of life assess symptoms of post traumatic stress

Locations

Country Name City State
France CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence/absence of cognitive impairment based on D2 test 4 months after ICU discharge No
Secondary Duration of sedation expected average of 48 hours No
Secondary Duration of ventilation expected average of 36 hours No
Secondary Daily average for RASS scale Expected maximum of 28 days No
Secondary Daily average for Behaviour pain scale expected average of 48 hours No
Secondary CAM ICU score upon awakening (expected average of 48 hours) No
Secondary Peritraumatic distress inventory expected average of 5 days (end of ICU stay) No
Secondary Questionnaire PDEQ-10 expected average of 5 days (end of ICU stay) No
Secondary Assessment of potential impacts expected average of 5 days (end of ICU stay) No
Secondary HADS score expected average of 5 days (end of ICU stay) No
Secondary ICUMT questionnaire 60 +- 3 days after ICU discharge No
Secondary ICU-SEQ questionnaire 60 +- 3 days after ICU discharge No
Secondary Assessment of psychotramatisme 60 +- 3 days after ICU discharge No
Secondary HADS score 60 +- 3 days after ICU discharge No
Secondary PCLS scale (DSM IV items) 4 months after ICU discharge No
Secondary IDS-C Questionnaire 4 months after ICU discharge No
Secondary SF-36 4 months after ICU discharge No
Secondary Forward span test 4 months after ICU discharge No
Secondary Backwards span test 4 months after ICU discharge No
Secondary Rey 15-word test 4 months after ICU discharge No
Secondary Test D2 (units = n) 4 months after ICU discharge No
Secondary Wisconsin test 4 months after ICU discharge No
Secondary Stroop test 4 months after ICU discharge No
Secondary Verbal fluency test 4 months after ICU discharge No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A